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Abstract 
Chronic Obstructive Pulmonary Disease (COPD) is due to chronic inflammation of the airways and 
lung parenchyma leading to either chronic airway obstruction, emphysema or both. It is mostly seen in 
smokers or former smokers but exposition to occupational or domestic noxious gases can also be a 
cause. It is treatable but not curable and currently is the fourth leading cause of death worldwide. The 
most disabling symptom is dyspnea, occurring at exercise or even at rest in severe disease. Some 
patients also complain of orthopnea, the occurrence or increase of breathlessness in the supine posture. 
Although it is a common symptom, the cause of orthopnea in COPD remains elusive and is poorly 
describe in literature. 
This study aims to assess the changes in respiratory mechanics occurring when switching from the 
sitting to the supine posture. Two techniques were used: the forced oscillation technique (FOT) and 
spirometry. Spirometry is the most commonly used technique in the clinic to measure lung function. 
The FOT consists in sinusoidal soundwaves sent by a loudspeaker into the airways in order to measure 
the respiratory system resistance and reactance. FOT was used to measure parameters related to 
respiratory resistance (R5, R20 and R5-20) and reactance (ΔX5, X5, X5in, X5ex and AX) and spirometry for 
the assessment of mobilized lung volumes and flows. These tests were performed in both position in 
20 normal subjects (control group), and 45 stable COPD subjects with variable disease severity, of 
whom 25 reported orthopnea. 
This study showed significant differences between the COPD and control groups for both FOT and 
spirometry parameters in both the sitting and the supine postures with more significant increase in 
small airways related parameters when adopting the supine position. FOT suggests the occurrence or 
increase in expiratory flow limitation since ΔX5 and X5ex were increased in the supine posture, 
particularly in the orthopneic group. Importantly, we observed a significant decrease in inspiratory 
capacity (IC) in COPD subjects while it increased in supine position in the control group, suggesting 
an increased functional residual capacity (FRC) in the COPD group as opposed to a decrease in the 
control group. In the COPD group, these changes were more pronounced in orthopneic patients. We 
also observed a correlation between changes in dyspnea and changes in AX, ΔX5, X5 and X5ex between 
sitting and supine.  
In conclusion, this study showed that the adoption of the supine position is associated with 
profound changes in small airway function in patients with COPD. These changes are more 
pronounced in orthopneic subjects and suggest that they are responsible for the occurrence or increase 
in expiratory flow limitation and dynamic lung hyperinflation which play a critical role in the genesis 
of dyspnea in COPD. 
Keywords: Chronic Obstructive Pulmonary Disease, Forced Oscillation, Spirometry, Supine 
position, Orthopnea  
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Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases 
worldwide. According to the World Health Organisation (WHO), 251 million cases were re-
ported around the world in 2016 and it was responsible for 3.17 million deaths in 2015. 
COPD was the fifth leading cause of death in 2002 [1], became the fourth in 2015, and the 
WHO anticipates that it will become the third cause of death worldwide before 2020 [2]. 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) (an international pan-
el aiming at disseminating guidelines about COPD) defines COPD as a common disease char-
acterised by permanent airflow obstruction as measured by spirometry and the presence of 
persistent respiratory symptoms.  
COPD is considered as a non-reversible disease due to chronic inflammation in the periph-
eral airways. Inhaled noxious particles and gases from tobacco smoking but also occupational 
exposure or pollution are responsible for this inflammation [3]. Host factors put some subjects 
at risk for developing the disease as demonstrated by the fact that some smokers never devel-
op COPD while others develop early disease due to a rare mutation in the gene coding for α1-
antitrypsin, a major serine protease inhibitor [1, 4]. Indeed, it has been demonstrated that 
smokers with a severe deficiency in α1-antitrypsin have an increased risk for developing more 
severe COPD at a younger age [5]. 
COPD includes subjects with both chronic bronchitis and emphysema although some sub-
jects with chronic bronchitis or emphysema do not have airflow obstruction and therefore do 
not meet the definition criteria for COPD.  
Nowadays no treatment exists to cure COPD but some drugs can relieve symptoms caused 
by the disease and slow down its progression. However, as demonstrated by Anthonisen et al. 
(1994) [6] the best and up to now only way to slow down the lung function decline is to stop 
smoking. Indeed, as represented on Figure 1, reproduced from Anthonisen, the decrease of 
forced expiratory volume in one second (FEV1) is more important in subjects who continued 
to smoke than in those who had stopped.  
 
Figure 1: Evolution of FEV1 in subjects who stopped smoking (empty circles) and in subjects who do not 
stopped (full circles). The FEV1 decline is faster in continuing smokers than in sustained quitters.
1
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1.1.1. Chronic bronchitis 
Chronic bronchitis has a clinical definition. It is defined by the presence of a productive 
cough for at least three months per year during two years. It is associated with an excess of 
phlegm in the airways caused by submucosal bronchial glands hypertrophy (Figure 2) and by 
an increase of the number of goblet cells in the airway epithelium. Together with increased 
connective tissue and smooth muscle in the airway wall, these factors concur to reduce airway 
diameter.  
 




On the other side, emphysema has a histological definition: it is characterised by the pres-
ence of permanent alveolar space enlargement associated with alveolar wall destruction. Since 
lung biopsies are not performed easily, the best way to detect emphysema in the clinical set-
ting is to perform a chest computerised tomography [7]. 
From a physiological point of view, emphysema is associated with a loss of lung elastic 
properties. Emphysema reduces the elastic recoil of the alveolar walls, which translates in 
increased lung compliance. Since alveoli cannot deflate normally, a larger volume of air will 
stay in the alveoli at end-expiratory lung volume (EELV) or functional residual capacity 
(FRC; Figure 3A) [8]. This increased lung volume is called lung hyperinflation. As discussed 
below, lung hyperinflation is a major determinant of dyspnea in COPD and other airway dis-
eases. Referring to Figure 3B, emphysema subject have an increased FRC as compared to 
healthy people.  
Since lung elastic recoil plays a critical role in the tethering of the small airways, emphy-
sema also reduces the diameter of these small airways.  
1.2. Dyspnea 
Dyspnea is the most disabling symptom for subjects with COPD. Dyspnea is the sensation 
to be out of breath [9], to experience laboured breathing [10]. However, because it is a subjec-
tive sensation, the American Thoracic Society decided to define dyspnea as “a term used to 
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characterize a subjective experience of breathing discomfort that consists of qualitatively dis-
tinct sensations that vary in intensity” [11]. 
 
 
Figure 3: A) Variation in lung volume compartments with and without emphysema. Emphysema is associated 
with an increased residual volume due to the enlargement of alveolar spaces secondary to emphysema, also 
leading to an increase in total lung capacity. IRV: inspiratory residual volume; Tidal V: tidal volume; ERV: 
expiratory residual volume; RV: residual volume.
3
  
B) Pressure-volume curve representing the elastic properties of the respiratory system (dotted 
lines) and its components: lungs and chest wall. The lung P-V curve is shifted upwards and leftwards in emphy-
sema (dark green) as compared to a healthy subject (light green) due to increased lung compliance. Chest wall 
compliance is the same for both subjects. The yellow dotted curve represents the sum of the chest wall and lung 
elastic properties in a subject with emphysema. Compared to the green dotted curve, it is easy to understand that 
FRC (corresponding to the equilibrium volume of the respiratory system, where recoil pressure is 0) is larger in 
emphysema due to the increase in lung compliance. RV: residual volume; FRC: functional residual capacity; 
TLC: total lung capacity.
4
 
However, dyspnea is not seen in all the subjects and its intensity depends on COPD severi-
ty and other factors. As dyspnea is subjective [12, 13], its severity depends on behavioural 
and psychological aspects [14].  
Some subjects are complaining of a worsening of dyspnea when they adopt the supine po-
sition. This is called orthopnea. Orthopnea is commonly observed in left heart failure but is 
also common in COPD where, unlike heart failure where orthopnea occurs after more or less 
two hours, orthopnea can appear after less than 10 minutes [15]. Unfortunately, although it is 
a common clinical finding, there is a paucity of data regarding orthopnea in COPD subject. 
Moreover, its pathogenesis is still not well understood [16]. 
Dyspnea is related to the load imposed on the inspiratory muscles and to the capacity of in-
spiratory muscles. More precisely, dyspnea is positively related to the inspiratory muscles 
workload and inversely related to their capacity. As discussed below, COPD has detrimental 
influences on these two dimensions. 
The inspiratory muscle workload has a resistive and an elastic component.  
The resistive component is directly proportional to airway resistance (Raw) and inspiratory 
flow. The elastic component is directly proportional to dynamic elastance and inspiratory vol-
ume. In COPD subjects, both Raw and dynamic elastance are usually increased. 
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According to the Poiseuille equation
5
, Raw is inversely proportional to the fourth power of 
airways radius [17, 18]. The latter is reduced by multiple factors in COPD, such as airway 
muscle and connective tissue hypertrophy, increased airway smooth muscle tone, increased 
mucus in the airway lumen, and reduced small airway tethering due to emphysema. Accord-
ingly, COPD is associated with increased Raw. 
The elastic properties of the respiratory system can be described by a pressure-volume 
(PV) curve (Figure 3B). The greater the elastance (which is the inverse of compliance), the 
greater the pressure drive needed to inflate the respiratory system (which translates in a flat-
tened or horizontal PV curve). Due to the decreased elastance of the emphysematous lung, it 
might be difficult to understand why COPD is associated with an increased elastic load im-
posed on the inspiratory muscles. This apparent discrepancy can be resolved when consider-
ing that severe COPD subjects breathe at higher lung volumes when compared to healthy sub-
jects. Accordingly, they breathe on a flatter portion of their respiratory system PV curve 
where elastance is increased. In fact, while healthy subjects have an EELV corresponding to 
the resting volume of their respiratory system (also known as the equilibrium volume); this 
EELV is higher than the resting volume in some COPD subjects. This phenomenon is called 
lung dynamic hyperinflation (DH).  
The cause of DH is the reduction of airway lumen calibre and the resultant decrease in 
maximal expiratory flows (Figure 4) and the associated expiratory flow limitation (EFL). 
When severe, airway obstruction can be associated with EFL during tidal breathing. Accord-
ingly, expiratory flows during tidal breathing are the maximal expiratory flow that can be 
generated in the airways. Indeed, as maximal expiratory flows progressively decrease, the 
resultant increase in expiratory time does not allow for adequate minute ventilation (VE) an-
ymore. In this situation, the only way to increase expiratory flows to maintain adequate alveo-
lar ventilation is to breathe at higher lung volumes, which corresponds to DH [19]. Initially, 
DH is only seen during physical exercise because of the higher VE (as can be seen from Fig-
ure 4) but as COPD worsens and maximal expiratory airflows decrease, it can even be present 
at rest.  
DH plays a major role in the occurrence of dyspnea in COPD. Indeed, its detrimental role 
is not limited to an increased dynamic elastance. As EELV is higher than the resting volume 
of the respiratory system in case of DH, the air surplus that stays in the lungs after expiration 
creates a positive end expiratory alveolar pressure (PEEP) which needs to be neutralised by 
the inspiratory muscles before they are able to generate a negative alveolar pressure which is 
the drive for the inspiratory flow. PEEP adds to the workload faced by the inspiratory mus-
cles. DH explains why dyspnea is influenced by reduced expiratory flows although it is a sen-
sation mainly driven by afferences generated at the level of respiratory muscles during the 
inspiratory phase of the breathing cycle. 
As can be seen from Figure 3B, the increased static lung compliance also plays a role to 
increase lung hyperinflation. Indeed, it increases the resting respiratory system volume. Ac-
cordingly, in case of emphysema associated with EFL, lung hyperinflation has both a dynamic 
and a static component. As already discussed, the inspiratory muscle workload is increased in 
the setting of COPD but lung hyperinflation also reduces the inspiratory muscle capacity. In-
deed, it is associated with a flattening of the diaphragm and a reduced height of its vertical 
and muscular portion called the zone of apposition. The shortening of the zone of apposition 
of the diaphragm is the basis for the inspiratory effect of the main inspiratory muscle. As the 
diaphragm is put at mechanical disadvantage with lung hyperinflation, the inspiratory effort 








must increase to inflate the lungs as compared to the normal situation. The reduced mechani-
cal efficiency of the diaphragm is associated with a neuromechanical uncoupling between the 
efferences from the brain stem respiratory centre and the resultant mechanical effect of the 
inspiratory muscles. This is thought to be a major factor in the genesis of dyspnea in 
COPD[20]. 
 
Figure 4: Flow volume curves from a healthy (left) and a COPD subject (right). The largest envelopes repre-
sent the flow-volume obtained during a forced expiratory maneuver from TLC to RV followed by a forced inspir-
atory maneuver from RV to TLC. The small envelopes represent the tidal breathing flow-volume loops recorded 




1.3. Diagnostic tools 
1.3.1. Spirometry 
There are different tests to evaluate respiratory function. The most commonly used in the 
clinical setting is spirometry (or forced vital capacity maneuver). It is usually assessed with a 
pneumotachograph, an instrument allowing for the measurement of inhaled and exhaled air-
flows. From the measurements of flow in function of time, changes of the respiratory system 
volumes during inspiratory or expiratory maneuvers can be measured [21]. 
The most important parameters measured at spirometry are recorded during a forced expir-
atory maneuver from total lung capacity (the volume of the respiratory system after maximal 
inhalation). These parameters are (Figure 5): 
 The FEV1 and 
 The forced vital capacity (FVC).  
From these parameters, a third important parameter is calculated:  
 The Tiffeneau index (FEV1/FVC).  
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Figure 5: Parameters measured by spirometry during a forced expiratory maneuver. As RV is a non mobiliz-
able volume, RV and TLC cannot be measured with a pneumotachograph. FEV1: forced expiratory volume in 
one second; FVC: forced vital capacity; RV: residual volume; TLC: total lung capacity.
7
  
A reduced Tiffeneau index is the criteria used to define the presence of airflow obstruction. 
According to GOLD, a diagnosis of COPD requires the presence of a reduced Tiffeneau index 
(defined in this case as lower than 70%) after bronchodilation [22]. Moreover, the level of 
FEV1 allows the assessment of airflow obstruction severity according to GOLD (Table 1). 
For a healthy subject, the graph representing airflow against lung volume during a forced 
expiration followed by a forced inspiration will be similar as the one seen on the left panel of 
Figure 4. In COPD, the graph will be different: expiratory flows are reduced for a given lung 
volume which can lead to EFL during tidal volume (VT) breathing as already discussed. The 
reduced expiratory flows are responsible for the characteristic upper concavity of the maximal 
forced expiratory flow-volume curve seen on the right panel of Figure 4. 
The major weakness of spirometry in the assessment of dyspnea is its poor association with 
the respiratory mechanics parameters that are associated with dyspnea such as airway re-
sistance, lung compliance, tidal EFL or lung hyperinflation. 
Table 1: Classification of airflow obstruction severity in subjects with COPD according to GOLD  
COPD severity Post-bronchodilator FEV1 (% predicted) 
GOLD 1: Mild ≥80 
GOLD 2: Moderate 50-79 
GOLD 3: Severe 30-49 
GOLD 4: Very Severe <30 
A FEV1/FVC<70% post-bronchodilator is required to make a diagnosis of COPD according to GOLD. 
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1.3.2. Body plethysmography 
Another test used in the clinic is the body plethysmography. Plethysmography is useful to 
assess some aspects of COPD since it can measure different parameters reflecting the func-
tional and structural aspect of the lungs [23]. Unlike spirometry, body plethysmography can 
measure the static lung volumes: residual volume (RV), functional residual capacity (FRC), or 
total lung capacity (TLC) and above all, Raw. Accordingly, it gives additional informations 
regarding the consequences of COPD, i.e. data regarding lung hyperinflation and Raw, which 
are of interest when assessing the cause and the severity of dyspnea. 
 
Figure 6: Sequence of static lung volume measurement by body plethysmography. VT: tidal volume; TLC: to-
tal lung capacity; IRV: inspiratory reserve volume; FRCpleth: functional residual capacity measured by whole 
body plethysmography; ERV: expiratory reserve volume; IC: inspiratory capacity; RV: residual volume; 
SVC/FVC: slow vital capacity/ forced vital capacity.
8
 
The measurement of FRC by body plethysmography relies on the Boyle-Mariotte’s law 
(which states that the product of the pressure and the volume of a gas are constant in isother-
mic conditions). The body plethysmograph is a closed box where the subjects can sit. While 
the subjects perform in- and expiratory efforts against a closed shutter valve (occluded breath-
ing), changes in box pressure and at the mouth (reflecting alveolar pressure) are recorded[23]. 
Pressure measured at the mouth during occluded breathing is a reflection of the alveolar gas 
pressure while pressure changes in the box reflect changes of thoracic and gas volume. 
The measurement of Raw by body plethysmography is an estimation made from calculation 
of the specific airway resistance (sRaw) and FRCpleth [24, 25]. sRaw is defined as the work 
needed to be made at a given volume to generate a flow rate [23]. 
Despite its advantages, the common body plethysmograph is not suited for the assessment 
of respiratory function in the supine position.  
Moreover, spirometry and body plethysmography both have other disadvantages. They re-
quire good collaboration from the tested subjects, which can limit their use in young children 
or older subjects. Finally, they do not assess EFL or impedance of the respiratory system be-
yond resistance. 
                                                 
8




1.3.3. Forced oscillation technique 
The forced oscillation technique (FOT) is a technique of non-invasive assessment of the 
respiratory mechanics based on the work of Dubois [26]. It consists in a sequence of sinusoi-
dal waves at various frequencies (from 5 to 37 Hz) produced by a loudspeaker-in-box sent 
through the mouth into the airways in order to assess the impedance of the respiratory system 
at different oscillation frequencies, while the subject breathes quietly (tidal breathing). Imped-
ance is composed of resistance (Rrs; represented by the upper curve on Figure 7) and reac-
tance (Xrs; which encompasses elastance and inertance; represented by the lower curve on 
Figure 7) of the respiratory system. They are measured by assessing the changes in volume 
and flows induced by the oscillating pressure signal superimposed on the tidal breath of the 
subject. Calculation of impedance is performed by a software using a fast Fourier transform 
analysis [27, 28] of the pressure, flow and volume signals.  
The FOT allows an evaluation of the small airways compartment which can be useful for 
the detection of early changes in illnesses such as asthma or emphysema [29]. Indeed, some 
oscillation frequencies are specific to small (peripheral) or larger (upper) airways. Frequen-
cies higher than 20 Hz are assessing the upper airways because they travel shorter 
distances.[30] On the other side, frequency of 5 Hz will measure the total impedance. There-
fore, subtracting R20 from R5 gives an index of peripheral airways resistance. In healthy adult 
subjects, resistance is almost independent of the oscillation frequency meaning that at low 
frequency such as 5 Hz the resistance will be more or less equal to the resistance measured at 
20 Hz (upper curve of the left panel of Figure 7) [30]. In COPD patients however, the re-
sistance will be dependent of the frequency due to small airway obstruction. Given that 5 Hz 
frequency will assess the total Rrs while 20 Hz will stop in upper airways then resistance 
measured at 5 Hz will be higher than that measured at 20 Hz (upper curve of the right panel of 
Figure 7). 
Reactance is frequency dependent for both normal and COPD subjects. However, in nor-
mal subjects the reactance curve (lower curve on the left panel of Figure 7) will cross the X 
axis at a frequency between 10 and 15 Hz, which is the resonant frequency (Fres). In COPD 
subjects, the reactance curve will be displaced downwards as compared to normal subject and 
accordingly, the Fres will be increased (lower curve on the right panel of the Figure 7). 
 
Reactance can be understood as a parameter assessing the elastic properties of the respira-
Figure 7: Graphs obtained using the FOT. The left panel represents the results of a normal subject and the right panel 
those of a COPD subject. The upper curve represents resistance in function of oscillation frequency and the lower curve 
represents reactance. The frequency of resonance is the frequency at which the reactance curve crosses the Y axis (i.e. the 
frequency at which reactance is 0). It can be seen that there is a frequency dependency of the resistance and that the reac-




tory system. However, small airway disease might influence reactance parameters measured 
by the FOT. Indeed the phenomenon of choke point associated with airflow limitation as well 
as the small airway closure phenomenon potentially increases the Xrs without influencing the 
static elastic properties of the lung. 
A parameter of particular interest is the ∆X5 which is the difference between the expiratory 
and inspiratory reactance at 5 Hz. This index is useful for the detection of EFL [31-33]. Del-
lacà et al.(2004) [34] used the Mead and Whittenberger method [35] in order to detect EFL 
and assess if there were some associations with FOT measurements. In this study, the authors 
showed an association between the increase in ∆X5 above a threshold and the presence of 
EFL. The disproportionate increase in X5 in the expiratory phase of the breathing cycle is ex-
plained by the appearance of a “choke point” when EFL occurs in an airway. When a choke 
point occurs, soundwaves produced by the FOT are stopped and cannot reach the alveoli 
which translates in an increased reactance. Flow limitation occurs only during expiration since 
the airway calibre is much lower in the small airways during the expiratory phase of the 
breathing cycle owing to a higher pleural pressure (which is less negative or even positive as 
compared to the inspiratory phase). According to Dellacà et al. (2007), a ∆X5 greater than 2,8 
cmH2O.s.L
-1
 would be an ideal criterion (100% sensitive and 100% specific) for the detection 
of EFL [36]. 
Accordingly, FOT had numerous advantages over common measurements of respiratory 
mechanics used in the clinic:  
 It brings more information on respiratory mechanics parameters of interest to ex-
plain dyspnea. 
 It only requires minimal collaboration from the subject since measurements are per-
formed during tidal breathing. 
 The apparatus is light and small enabling its use in the supine posture.  
1.4. Expectations 
Based on the literature, some changes are expected concerning spirometric’s parameters in 
the supine posture such as a decrease in FEV1, FVC, VC and an increase in IC in the control 
group [37]. However, there is a lack of literature on these changes for COPD subjects. 
One can also assume that there will be some changes in resistance and reactance parame-
ters for both COPD and normal subjects since de gravity will have a different effect on the 
lungs and on pleural pressure. As the volume of lung in the dependent region increases in the 
supine posture, one can imagine that the pleural pressure will be less negative for a greater 
portion of the total lung volume in this position [38]. Therefore, a bigger part of the airways 
will have a reduced diameter what will tend to increase resistance. This decreased diameter 
will also increase the potential for the occurrence of EFL giving increased ΔX5 and X5ex. In 
small airways, this reduction of the diameter might also lead to airway closure that can also 
influence reactance parameters as stated above [39]. 
2. Specific Aims 
The study aims to assess the effect of the dorsal supine posture on respiratory mechanics in 
both COPD and healthy subjects. Although there is no thorough description in the literature, it 
is a common clinical finding that many subjects with COPD are complaining of orthopnea. In 
subjects with severe left heart failure, orthopnea is a typical symptom. It is explained by a 
shift of venous blood from the lower limbs and splanchnic organs to the thorax which increas-




sures. This leads to vascular distension and perivascular, peribronchiolar and interstitial oe-
dema. There is however no evidence that these changes play a role in COPD [40] where the 
causes of orthopnea remain elusive. The present study will assess different aspects of the res-
piratory system mechanics using the FOT in order to get better insight in the cause of or-
thopnea in COPD. 
To assess the changes of respiratory mechanics, different parameters were measured. Pa-
rameters measured by the FOT such as R5, R20, R5-20, AX, X5 and ∆X5 were chosen. They 
may give a better understanding on the mechanisms leading to orthopnea than spirometry.  
In addition, FEV1, FVC, the derived Tiffeneau index, inspiratory capacity (IC), vital capac-
ity (VC) and forced expiratory flow at low lung volumes (FEF50, FEF75) were also measured 
by spirometry. FEF50 and FEF75 are 2 indices of small distal airway function. A reduced 
FEF50 or FEF75 without any reduction of the Tiffeneau index has been used as an index of 
early airway obstruction.  
As EELV (or FRC) influences airway resistance –Raw being lower at higher lung volumes– 
and as FRC was not measured in the present study, we used the IC to assess the changes in 
EELV. Indeed, postulating an unchanged TLC [41] with the change in posture, a higher IC 
reflects a decreased EELV while a decrease in IC reflects an increased EELV. The latter was 
important since Raw is influenced by lung volumes. 
3. COPD and normal subjects 
Recruitment of COPD and healthy subjects started once the Ethical Committee of Mont-
Godinne gave approval for the protocol. Prof. Marchand recruited COPD subjects at the am-
bulatory COPD clinic of the CHU-UCL Namur, site Godinne. Advertisements were displayed 
in University of Namur in order to recruit healthy volunteers. Some partners of recruited 
COPD subjects were also proposed to participate in the study as healthy volunteers. Inclu-
sions/exclusions criteria for study participation are shown in Table 2.  
Smokers and former smokers were accepted in the control group as it had already been 
demonstrated that smoking had no significant influence on FOT in healthy smokers [42, 43]. 
During recruitment two subjects refused to participate in the study, one did not show to the 
appointment, two were excluded due to an ongoing exacerbation; six had to be excluded for 
the analysis due to either insufficient collaboration for some measurements or problems in 
reproducibility. 
Two subjects recruited as healthy smoker were diagnosed with COPD at the time of spi-
rometry (reduced Tiffeneau index) and were included in the COPD group. Another healthy 
non-smoking volunteer was diagnosed with airway obstruction of unknown cause and was 











In order to assess the effects of position on respiratory mechanics and function, measures 
were made using the TREMOFLO
TM
 (Thorasys Thoracic Medical System Inc, Montreal, 
Canada) for the FOT and Spirobank II (Medical International Research Inc, Rome, Italia) for 
spirometry.  
Once the subject had completed a questionnaire (see annex 1), weight and height, hip and 
waist circumference were measured. The body mass index (BMI) and the waist to hip ratio 
were calculated. The latter parameter was recorded since it was hypothesized that abdominal 
obesity could influence respiratory mechanics in the supine position. 
Respiratory function measurements started with the FOT. Three sets of runs were record-
ed: 
1. In the sitting position on a chair. 
2. In the supine position on a flat examination table. 
3. Again in the sitting position on a chair.  
The second set of measurements in the sitting posture was included in the protocol in order 
to ascertain that the differences observed between the sets of measurements were indeed due 
to the change in position rather than to other uncontrolled confounding factors. 
For all the FOT measurements, the neck was placed in slight extension (~15°). Subjects 
breathed through a mouthpiece and wore a nose clip. Before starting the test, it was checked 
that the lips were sealed around the mouthpiece. During the FOT measurements, the subjects 
were asked to compress their cheeks with their hands in order to avoid any bias due to cheeks 
compliance (Figure 8) [27, 44]. For each run, subjects breathed spontaneously (tidal breath-
Table 2:Inclusion and exclusion criteria 
 COPD subjects Healthy subjects 
Inclusion 
criteria 
- COPD confirmed by pulmonary 
function tests; 
- Smoker (old or current); 
- Age ( >40 years old); 
- Signed informed consent. 
- Age ( >40 years old); 
- Signed informed consent. 
Exclusion 
criteria 
- Severe obesity (BMI > 35 kg/m2); 
- Pregnant woman; 
- Presence of other respiratory dis-
ease. 
- Heart failure requiring diuretics; 
- Use of oral corticosteroids or anti-
biotics within 14 days; 




- Pregnant woman; 
- Heart failure requiring diu-
retics; 





ing); once breathing was stable, oscillations waves were imposed within the airway through 
the mouth. Runs of 20 seconds were recorded. The duration of the run was increased in case 
of very low breathing frequency. Care was given to avoid coughing, glottis closure or swal-
lowing artefacts.  
In each of the three positions, three valid runs with less than 15% coefficient of variation 
had to be achieved [45]. Subjects were excluded if this requirement was not met after eight 
runs in any position. FOT parameters used for the analysis were the mean of the measure-
ments achieved in the three valid runs.  
After each set of runs of FOT measurements in a given posture, spirometry took place for 
the assessment of the IC in order to assess changes in EELV, postulating an unchanged TLC 
in the different postures  as discussed before [41].  
For IC measurement, the subject had to achieve a regular normal breathing (tidal breath-
ing) before being asked to perform a maximal slow inspiratory maneuver up to TLC followed 
by a complete and slow expiration down to RV, allowing for the measurement of slow expira-
tory VC  (EVC on Figure 9, reported as VC in the results section) [21]. A minimum of three 
acceptable IC maneuvers were recorded, with the difference between the two best values not 
being greater than 150 mL. The larger value of these two measurements was retained for the 
analysis. 
As forced expiratory maneuvers are known to induce changes in Raw in some subjects, this 
maneuver was only performed after all FOT and IC measurements were achieved in the three 
different sets. For the forced expiratory maneuver, the subject had to breathe spontaneously 
two or three times, to make a maximal inspiration to TLC, to expire immediately as fast as 
possible down to RV. 
 
Figure 8: Description of the body posture during FOT measurements in the sitting position. Hands are sup-
porting the cheeks; the head is in slight extension.  
A minimum of three acceptable maneuvers were recorded, with the difference between the 
two best values of FEV1 and FVC not being greater than 150 mL or 5% whichever was great-
er. The larger value of these two measurements was retained for the analysis and for the Tiff-
eneau index calculation. The forced expiratory maneuver was only performed in two sets of 





Figure 9: Inspiratory capacity and vital capacity maneuver. The subject starts breathing normally before 
taking a deep inspiration up to TLC and then exhaling down RV. The IC is the difference between TLC and FRC. 
TLC: total lung capacity; FRC: functional residual capacity; RV: residual volume; IC: inspiratory capacity; 
EVC: expiratory vital capacity.
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4.2. Statistical Analysis 
Data are presented as mean +/- standard deviation. Comparisons between the three pos-
tures were performed using a repeated measure ANOVA.  
As discussed below, we only found some small differences between the two sets of meas-
urements performed in the siting posture. Accordingly, for further analysis, only the first set 
of runs performed in the sitting posture was retained for analysis. 
Comparison between normal and COPD subjects or between orthopneic and non orthopne-
ic subjects were performed with an unpaired t-test, Aspin-Welch test (in case of unequal vari-
ances between groups) or Wilcoxon-Mann-Whitney test (when data distribution was not 
Gaussian), as required.  
Comparisons between proportions were performed using a Pearson’s chi-square test. 
The association between the change in dyspnea VAS between the sitting and the supine 
postures and other parameters was tested using a linear regression analysis.  
Statistical significance was set at p<0,05. 
5. Results 
5.1. Characteristics of the study population in the sitting position 
As can be seen from Table 3, both populations – controls and COPD – had similar anthro-
pometric characteristics and gender representation but COPD subjects were significantly older 
than controls (p<0,001). 
Fourteen (31%) and eight (17%) COPD patients described themselves as usually or some-
times orthopneic in the everyday life, respectively. Accordingly, nearly 50% of the included 
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patients reported having experienced orthopnea. 
Table 3: Subjects characteristics, dyspnea and forced expiratory measurements in the sitting position and comparison 
between groups 
 Controls (n=20) COPD (n=45) P value 
Orthopnea (Yes/Sometimes/No) 0/0/0 14/8/23 <0,001 
Dyspnea VAS 0,23±0,66 1,89±2,21 <0,01 
Gender (male/female) 9/11 24/21 NS 
Smokers/Ex-Smokers/Non Smokers 2/3/15 7/38/0 <0,001 
Age (y) 54,46 ± 8,56 64,89 ± 8,56 <0,001 
Weight (kg) 69,06 ± 15,42 66,16 ± 16,63 NS 
Height (cm) 169,2 ± 10,99 164,8 ± 10,52 NS 
Waist/Hip 0,82±0,11 0,95±0,11 <0,001 





GOLD I/II/III/IV NA 2/13/15/15 NA 
FEV1 (L) 3,43 ± 1,01 1,14 ± 0,61 <0,001 
FEV1 (% pred) 105,09 ± 12,66 42,5 ± 19,26 <0,001 
FVC (L) 4,32 ± 1,32 2,53 ± 0,97 <0,001 
FVC (% pred) 101,87 ± 11,28 73,13 ± 19,46 <0,001 
FEV1/FVC (%) 79,65 ± 5,29 44,58 ± 12,78 <0,001 
FEF50 (L/sec)) 3,85±1,43 0,57±0,5 <0,001 
FEF75 (L/sec) 1,2±0,47 0,22±0,14 <0,001 
SpO2 (%) NM 96,37±1,56 NA 
Values are presented as mean ± SD. NS: not significant; NM: not measured; NA: not applicable; BMI: body 
mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; FEF50: forced expiratory 
flow when 50% of the volume has been expired; FEF75: forced expiratory flow when 75% of the volume has 
been expired; SpO2: oxygen saturation. 
GOLD stage 2, 3 and 4 were quite equally represented in the COPD group but stage 1 was 
underrepresented.  
Per protocol, spirometric’s parameters in the control group were within normal values, 
while FEV1 and FEV1/FVC were significantly lower in the COPD subjects. This was also the 
case for FVC, FEF50 and FEF75.  
Table 4: Comparison of FOT measurements between the control and COPD groups in the sitting position 
Values are presented as mean ± SD. VAS: visual analogue scale; R5: resistance at 5 Hz; R20: resistance at 20 
Hz; R5-20: difference between the resistance at 5 Hz and the resistance at 20 Hz; X5: reactance at 5 Hz; ΔX5: 
difference in reactance measured at 5 Hz between inspiration and expiration; X5in: inspiratory reactance at 5 Hz; 
X5ex: expiratory reactance at 5 Hz; AX: area under the reactance-frequency curve. 
All FOT parameters were significantly higher (p<0,001) in COPD compared to control 
subjects, except for X5 which was significantly lower in the COPD group, reflecting a greater 
derangement in the reactance of the respiratory system. 
 Controls (n=20) COPD (n=45) P value 
R5 (cmH2O.s/L) 2,79±0,77 5,38±1,51 <0,001 
R5 (% pred) 106,08±31,55 187,44±57,82 <0,001 
R20 (cmH2O.s/L) 2,64±0,67 3,53±1,07 <0,001 
R20 (% pred) 94,11±20,5 123,74±32,97 <0,01 
R5-20 (cmH2O.s/L) 0,16±0,32 1,85±0,95 <0,001 
X5 (cmH2O.s/L) -1,20±0,35 -4,67±2,82 <0,001 
X5 (% pred) 112,5±27,68 412,5±314,3 <0,001 
∆X5 (cmH2O.s/L) -0,50±0,32 2,90±3,36 <0,001 
X5in (cmH2O.s/L) -1,48±0,49 -2,92±1,11 <0,001 
X5ex (cmH2O.s/L) -0,98±0,30 -5,83±4,13 <0,001 
AX (cmH2O/L) 4,60±2,94 48,52±31,65 <0,001 




Fres was not included in the analysis since 12 COPD subjects had a Fres in excess of the 
highest oscillating frequency used in the present protocol (35 Hz) in both the sitting and the 
supine postures.  
Taking into account the 2,8 cmH2O.s/L ΔX5 threshold as a surrogate for EFL [36], none of 
the subjects in the control group presented EFL while 18 COPD patients experienced EFL in 
the sitting position. 
5.2. Influence of posture in controls and COPD subjects 
The dyspnea VAS was increased in 25 of the COPD subjects in the supine as compared to the 
sitting position but only in two of the control subjects. VAS only increased significantly 
(p<0,001) in the supine position in the COPD group.  
As can be seen from Table 5 and Figure 10, adopting the supine position was associated 
with important changes in both resistance and reactance parameters in the COPD population. 
These changes were less striking in control subjects. Indeed, the most important changes were 
seen for R5 and R20 in the control group but parameters related to small airway resistance (R5-
20) or reactance were less (X5 and X5in) or not significantly influenced by the supine position 
in normal subjects. 
The breathing pattern was not affected by the posture in controls. Minute ventilation, tidal 
volume and breathing frequency were reduced in COPD patients when adopting the supine 
position. These changes were significant. 
As expected, the IC was significantly increased in the supine position in the control sub-
jects. COPD subjects however had a significantly decreased IC in the supine position. The VC 
was slightly but significantly decreased in the supine position in both groups. 
As expected, we observed a significant reduction in the various spirometric’s parameters in 
the supine position, both in the control and in COPD populations except for the FVC that was 
only significantly decreased in the supine position in the control group. However, FEF50 and 
FEF75 were not significantly decreased in control and COPD groups. 
The second run in the sitting position was used in order to ascertain that changes observed 
from the first sitting run to the supine position were due to the change of position rather to 
other uncontrolled potential confounding factors. Quite unexpectedly, there were significant 
differences between the first and second sets of measures acquired in the sitting position. 
None of the parameters measured by FOT were significantly changed in COPD subjects but 
we observed a significant increase in the breathing frequency (Table 5) in the second run. 
There was also a significant decrease in the second measurement in the sitting position for 
both IC and VC. These small differences might be due to the fatigue of some patients at the 
end of the recordings, after multiple runs of measurements. In the control group, we did not 
find any significant difference between the two sets of measures in the sitting position neither 
for FOT nor spirometry. As the changes observed between the two sets of measurements in 
the sitting posture in COPD subjects were small and probably related to fatigue, we always 
used the results obtained in the first set of runs obtained in the sitting position for further 




Table 5: Changes between positions according the condition 
 Controls (n=20) COPD (n=45) 
 Sit 1 Supine Sit 2 P value Sit 1 Supine Sit 2 P value 
Dyspnea VAS 0,23±0,66 0,16±0,39 0,12±0,4 NS 1,89±2,21 2,87±2,85
* 
2,15±2,09 <0,001 







R20 (cmH2O.s/L) 2,64±0,67 3,65±0,84
* 
2,77±0,72 <0,001 3,53±1,07 4,33±1,52
* 
3,6±1,13 <0,001 
R5-20 (cmH2O.s/L) 0,16±0,32 0,38±0,54
* 
0,20±0,390 <0,01 1,85±0,95 2,56±0,91
* 
2,06±0,91 <0,001 























X5ex (cmH2O.s/L) -0,98±0,30 -1,34±1,24
 





AX (cmH2O/L) 4,60±2,94 6,36±7,29
 





VT (L) 0,75±0,32 0,81±0,36 0,73±0,35 NS 0,88±0,43 0,81±0,34
†
 0,81±0,35 <0,05 









VE (L/min) 11,65±3,87 11,01±3,52 11,53±3,54 NS 13,20±5,02 11,37±3,68
* 
13,03±4,66 <0,001 
IC (L) 2,96±0,78 3,45±1
* 





VC (L) 4,06±1,05 3,93±1,03
† 
4,02±1,07 <0,01 2,90±0,97 2,74±0,93
†
 2,80±0,93 <0,001 
FEV1 (L) 3,24±0,84 2,95±0,80
† 
NA <0,001 1,14±0,62 1,09±0,60
† 
NA <0,001 
FEV1 (% pred) 103±11,55 94,2± 11,74
† 
NA <0,001 42,73±19,41 40,91±18,77
† 
NA <0,001 
FVC (L) 4,08±1,10 3,80±1,04
† 
NA <0,001 2,55±0,97 2,49±0,95
 
NA NS 
FVC (% pred) 101,87± 91,16±11,13
† 
NA <0,001 73,17±19,42 71,66±19,22 NA NS 
FEV1/FVC (%) 79,67±5,35 77,76±5,64
† 
NA <0,001 44,44±12,38 43,20±12,39
† 
NA <0,05 
FEF50 (L/sec) 3,85±1,43 3,46±1,21 NA NS 0,57±0,5 0,52±0,48 NA NS 
FEF75 (L/sec) 1,2±0,47 0,98±0,43 NA NS 0,22±0,14 0,2±0,14 NA NS 
SpO2 (%) NM NM NM NA 96,37±1,56 95,2±2,52
*
 96,2±1,25 <0,001 
Values are presented as mean ± SD. NM: not measured; NS: not significant; VAS: visual analogue scale; R5: resistance at 5 Hz; R20: resistance at 20 Hz; R5-20: difference 
between the resistance at 5 Hz and the resistance at 20 Hz; X5: reactance at 5 Hz; ΔX5: difference in reactance measured at 5 Hz between inspiration and expiration; X5in: 
inspiratory reactance at 5 Hz; X5ex: expiratory reactance at 5 Hz; AX: area under the reactance-frequency curve; VT: tidal volume; BF: breath frequency; VE: minute ventila-
tion; IC: inspiratory capacity; VC: vital capacity; FEV1: forced expired volume in one second; FVC: forced vital capacity; FEF50: forced expiratory flow when 50% of the 
volume has been expired; FEF75: forced expiratory flow when 75% of the volume has been expired; SpO2: oxygen saturation. Statistical analysis: 
*
: significant difference 
between supine and the two sitting position; 
†
: significant difference with sitting 1; 
‡




5.3. Comparison of changes observed from the sitting to the supine posture between COPD 
and control subjects 
When comparing the changes in dyspnea assessed by the VAS with position between con-
trols and COPD, we observed a significant. Increase in dyspnea in the COPD group while in 
the control group the trend was a decrease in the supine position. 
There were no significant differences between COPD and control group for the change in 
R5 and R20 with position while the change was significantly greater for R5-20 in the COPD 
group. For all the parameters related to the reactance of the respiratory system, the changes 
observed when adopting the supine position were significantly greater in COPD than in con-
trols. The differences in reactance changes between control and COPD subjects were more 
obvious in the expiratory phase of the breathing cycle, as demonstrated by the changes in X5ex 
and ∆X5. 
 
Figure 10: Comparison of sitting and supine position for R5 (panel A), R20 (panel B), R5-20 (panel C), ∆X5 (panel 
D), X5 (panel E) and AX (panel F) in the control (Ctrl) and COPD groups. Results are represented as 




Table 6: Comparison of the changes from the sitting to the supine posture in dyspnea, FOT and slow vital capacity pa-
rameters in the control and COPD subjects 
Values were presented as mean ± SD. NS: not significant; VAS: visual analogue scale; R5: resistance at 5 
Hz; R20: resistance at 20 Hz; R5-20: difference between the resistance at 5 Hz and the resistance at 20 Hz; X5: 
reactance at 5 Hz; ΔX5: difference in reactance measured at 5 Hz between inspiration and expiration; X5in: 
inspiratory reactance at 5 Hz; X5ex: expiratory reactance at 5 Hz; AX: area under the reactance-frequency 
curve; VT: tidal volume; BF: breath frequency; VE: minute ventilation; IC: inspiratory capacity; VC: vital 
capacity. 
Interestingly, the change in IC in the supine position was strikingly different between the 
two groups: IC increased in the control group as expected, while in the COPD group, there 
was a significant decrease in IC when adopting the supine position. 
Taking into account the 2,8 cmH2O.s/L ΔX5 threshold as a surrogate for EFL, [36] 1 nor-
mal subject presented with EFL in the supine posture. This subject was a 72 years old woman 
also demonstrating an increase in both R5-20 and AX in the supine posture. However, she did 
not present any signs of significant airway obstruction when lung function was measured by 
spirometry. In the COPD group, 31 had signs of EFL in the supine posture; 17 out of the 18 
patients with EFL in the sitting posture also had EFL in the supine position.  
5.4. Comparisons between orthopneic and non orthopneic COPD subjects in the eve-
ryday life 
 For these comparisons, the 22 patients (49% of the COPD group) describing themselves as 
orthopneic (n = 14) or sometimes orthopneic (n=8) were grouped (orthopneic patients in fur-
ther analysis) and compared to the patients not complaining of orthopnea in the daily life 
(n=23).  
5.4.a. Comparison of anthropometric and other general parameters 
No significant differences between orthopneic and non-orthopneic patients were observed 
regarding gender, age, weight, height, BMI or GOLD stage (Table 7). However, even if the 
BMI was not significantly different between the two groups the waist to hip ratio was signifi-
cantly lower in the orthopneic group compared to the non-orthopneic group.  
 
 Controls (n=20) COPD (n=45) P value 
Dyspnea VAS -0,07±0,45 0,94±1,46 <0,01 
R5 (cmH2O.s/L) 1,23±0,61 1,51±1,14 NS 
R20 (cmH2O.s/L) 1,01±0,56 0,8±0,86 NS 
R5-20 (cmH2O.s/L) 0,22±0,39 0,71±0,79 <0,01 
X5 (cmH2O.s/L) -0,28±0,65 -2,25±2,46 <0,001 
∆X5 (cmH2O.s/L) 0,20±084 2,82±3,44 <0,001 
X5in (cmH2O.s/L) -0,16±0,38 -0,62±0,81 <0,01 
X5ex (cmH2O.s/L) -0,36±1 -3,42±3,82 <0,001 
AX (cmH2O/L) 1,76±4,65 21,54±27,54 <0,001 
VT (L) 0,06±0,22 -0,07±0,21 <0,05 
BF (cycle/min) -2,05±2,56 -1,06±2,61 NS 
VE (L/min) -0,64±2,96 -1,83±2,69 NS 
IC (L) 0,49±0,36 -0,1±0,28 <0,001 




5.4.b. Comparison of parameters recorded in the sitting position  
Table 7: Comparison of the parameters recorded in the sitting position in strict orthopneic and non-orthopneic subjects 
Values were presented as mean ± SD. NS: not significant; BMI: body mass index; VAS: visual analogue 
scale; R5: resistance at 5 Hz; R20: resistance at 20 Hz; R5-20: difference between the resistance at 5 Hz and the 
resistance at 20 Hz; X5: reactance at 5 Hz; ΔX5: difference in reactance measured at 5 Hz between inspiration 
and expiration; X5in: inspiratory reactance at 5 Hz; X5ex: expiratory reactance at 5 Hz; AX: area under the reac-
tance-frequency curve; VT: tidal volume; BF: breath frequency; VE: minute ventilation; IC: inspiratory capacity; 
VC: vital capacity; FEV1: forced expired volume in one second; FVC: forced vital capacity; FEF50: forced expir-
atory flow when 50% of the volume has been expired; FEF75: forced expiratory flow when 75% of the volume 
has been expired; SpO2: oxygen saturation. 
*
 These parameters were significant (p value <0,05) when excluding 
a large outlier from the non-orthopneic group. 
As can be seen in Table 7, subjects with or without orthopnea in everyday life did not sig-
nificantly differ for parameters measured in the sitting position except for: 
 dyspnea VAS which was higher in orthopneic patients; 
 IC and FVC expressed in absolute values which were significantly lower in orthopneic 
patients. 
When excluding one large outlier from the non-orthopneic group some parameters were 
significantly higher in the orthopneic group:  
 R5  
 X5in. 
Taking into account the 2,8 cmH2O.s/L ΔX5 threshold as a surrogate for EFL [36], 11 out 
 Non-orthopneic(n=23) Orthopneic (n=22) P value 
Dyspnea VAS 1,15±1,70 2,66±2,45 <0,05 
GOLD stage (I/II/III/IV) 2/6/8/7 0/7/7/8 NS 
Gender (F/M) 9/14 12/10 NS 
Age (y) 64,3±8,98 65,5±8,28 NS 
Weight (kg) 68,06±17,62 64,14±15,77 NS 
Height (cm) 167,45±10,92 161,95±9,48 NS 
BMI (cm/kg²) 24,16±5,21 24,5±4,99 NS 
Waist/Hip 0,98±0,11 0,91±0,1 <0,05 
R5 (cmH2O.s/L) 5,05±1,40 5,73±1,57 =0,13
*
 
R20 (cmH2O.s/L) 3,4±1,18 3,67±0,96 NS
 
R5-20 (cmH2O.s/L) 1,49±1,22 2,07±1,16 NS 
X5 (cmH2O.s/L) -3,95±2,38 -5,44±3,09 NS 
∆X5 (cmH2O.s/L) 2,25±3,10 3,59±2,54 NS 
X5in (cmH2O.s/L) -2,6±0,71 -3,26±1,35 =0,06
*
 
X5ex (cmH2O.s/L) -4,85±3,62 -6,85±4,45 NS
 
AX (cmH2O/L) 40,26±25,74 54,15±35,39 NS 
VT (L) 0,99±0,47 0,77±0,36 NS 
BF (cycle/min) 14,81±5,29 17,56±5,05 NS 
VE (L/min) 13,61±5,49 12,77±4,57 NS 
IC (L) 2,54±0,87 2,12±0,65 <0,05 
VC (L) 3,14±1,04 2,66±0,85 NS 
FEV1 (L) 1,30±0,70 0,97±0,47 NS 
FEV1 (%) 46,61±22,17 38,69±15,52 NS 
FVC (L) 2,85±1,01 2,23±0,85 <0,05 
FVC (%) 77,8±18,94 66,75±20,48 NS 
FEV1/FVC (%) 45±14,18 43,86±10,48  NS 
FEF50 (L/sec) 0,7±0,62 0,44±0,29 NS 
FEF75 (L/sec) 0,25±0,18 0,19±0,08 NS 




of the 22 subjects describing themselves as orthopneic (50%) present an EFL in sitting posi-
tion against 7 out of the 23 non orthopneic subjects(30%). The difference between the two 
groups was not significant. 
 
5.4.c. Comparison of parameters recorded in the supine position  
 
In the supine position, there were more clear-cut differences between orthopneic and non-
orthopneic COPD subjects, as shown in Table 8.  
Regarding resistance parameters, both R5 and R20 measured in the supine position were 
significantly higher in the orthopneic group while there was no significant difference for R5-20 
(p = 0,08). 
AX was significantly increased in the orthopneic group and there was a strong tendency for 
larger impairment in the other reactance parameters as well. These all became significant after 
exclusion of the large outlier in the non orthopneic group. These appeared to be more im-
portant in the expiratory phase of the breathing cycle, as reflected by the important differences 
in ∆X5 and X5ex, as compared to X5in. 
Figure 11: Comparison of sitting and supine position for R5 (panel A), R20 (panel B), R5-20 (panel C), ∆X5 (panel D), X5 
(panel E) and AX (panel F) in the non-orthopneic and orthopneic groups. Results are represented as median, 
interquartile (boxes upper and lower limits), and ± 1,5 interquartile ranges (whiskers). Individual 




Taking into account the 2,8 cmH2O.s/L ΔX5 threshold as a surrogate for EFL[36], respec-
tively 18/22 (82%) orthopneic subjects and 13/23 (56%) non-orthopneic subjects presented 
with EFL in the supine posture. The difference was not significant between the two groups 
(p=0,07).  
Orthopneic subjects had a significantly lower IC, FEV1 and FVC when expressed in abso-
lute values, without any differences in breathing pattern.  
Table 8: Comparison of the parameters recorded in the supine position in orthopneic and non-orthopneic subjects 
Values were presented as mean ± SD. NS: not significant; BMI: body mass index; VAS: visual analogue scale; 
R5: resistance at 5 Hz; R20: resistance at 20 Hz; R5-20: difference between the resistance at 5 Hz and the resistance 
at 20 Hz; X5: reactance at 5 Hz; ΔX5: difference in reactance measured at 5 Hz between inspiration and expira-
tion; X5in: inspiratory reactance at 5 Hz; X5ex: expiratory reactance at 5 Hz; AX: area under the reactance-
frequency curve; VT: tidal volume; BF: breath frequency; VE: minute ventilation; IC: inspiratory capacity; VC: 
vital capacity; FEV1: forced expired volume in one second; FVC: forced vital capacity; FEF50: forced expiratory 
flow when 50% of the volume has been expired; FEF75: forced expiratory flow when 75% of the volume has 
been expired; SpO2: oxygen saturation. 
*
 These parameters were significant (p value <0,05) when excluding a 
large outlier from the non-orthopneic group.  
5.5. Correlation between the changes in dyspnea VAS from the sitting to the supine 
position and various parameters in the COPD subjects 
 
As expressing orthopnea according to dyspnea VAS as a binary parameter might induce a 
loss of information, we also assessed dyspnea during the experimental procedures in a quanti-
tative manner by using a dyspnea VAS. We looked at the correlation between the absolute 
change in dyspnea VAS when adopting the supine position and anthropometric characteristics 
and the various parameters recorded in the sitting and the supine position as well as their 
changes with position. The change in dyspnea VAS with position was only significantly cor-
related with changes observed between the sitting and supine positions for the following pa-
rameters: ∆X5, X5, X5ex and AX (p<0,01 for all correlations) (Figure 12). 
 
 Non-orthopneic(n=23) Orthopneic (n=22) P value 
Dyspnea VAS 1,5±2,02 4,3±2,91 <0,001 
R5 (cmH2O.s/L) 6,28±1,92 7,55±1,77 <0,05 
R20 (cmH2O.s/L) 3,91±1,5 4,78±1,45 <0,05 
R5-20 (cmH2O.s/L) 2,37±0,92 2,77±0,88 NS 
X5 (cmH2O.s/L) -5,94±2,91 -7,595±3,72 =0,06
* 
∆X5 (cmH2O.s/L) 4,71±4,18 6,79±4,67 =0,1
* 
X5in (cmH2O.s/L) -3,27±0,88 -3,82±1,15 =0,08
* 
X5ex (cmH2O.s/L) -7,94±4,58 -10,61±5,49 =0.08
* 
AX (cmH2O/L) 58,25±32,78 82,41±41,02 <0,05 
VT (L) 0,88±0,34 0,73±0,32 NS 
BF (cycle/min) 14,27±4,8 15,95±4,77 NS 
VE (L/min) 11,8±3,9 10,92±3,48 NS 
IC (L) 2,42±0,77 2,04±0,74 <0,05 
VC (L) 3±0,92 2,47±0,87 =0.06
*
 
FEV1 (L) 1,25±0,67 0,92±0,48 <0,05 
FEV1 (% pred) 44,74±20,58 36,9±16,19 NS 
FVC (L) 2,81±0,99 2,15±0,79 <0,05 
FVC (% pred) 76,53±18,27 66,56±19,25 NS 
FEV1/FVC (%) 44,04±13,52 42,32±11,34 NS 
FEF50 (L/sec) 0,53±0,58 0,41±0,3 NS 
FEF75 (L/sec) 0,23±0,17 0,18±0,09 NS 





































An increase in VAS was thus as-
sociated with an increased derange-
ment of these reactance measure-
ments when adopting the supine pos-
ture. We also observed a poor but 
significant correlation with the 
breathing frequency recorded in the 
sitting posture (p=0,03) (Figure 13). 
All correlation coefficients were 





Figure 12: Graphs representing the regression line and the relationship between the changes in 
dyspnea VAS from the sitting to the supine position (X axis) and the change from sitting 
to supine position in ΔX5 (panel A), AX (panel B), X5 (panel C) and X5ex (panel D). 




Figure 13: Graph representing the regression line and the re-
lationship between the changes in dyspnea VAS from the sitting to 




6. Analysis and Discussion 
Orthopnea is a frequent clinical finding in COPD. This is confirmed by statements of the 
COPD subjects included in the present study which were non selected stable patients without 
hypoxemic respiratory insufficiency from a tertiary care ambulatory COPD clinic. Indeed, 14 
(31%) and eight (17%) of them described themselves as usually or sometimes orthopneic in 
the everyday life respectively. Among these orthopneic patients, 13 out of the 14 subjects who 
reported orthopnea in everyday life had the sensation of increased breathlessness when adopt-
ing the supine posture in the experimental protocol, five who previously said that they some-
times had the orthopnea experienced it during the test and seven out of the 23 who said that 
they never had orthopnea had actually an increased dyspnea VAS in the supine posture.  
In the following discussion, we will discuss in more details the main findings of the present 
study. First, we will briefly discuss the already well described differences that can be found in 
COPD subjects compared to normal subjects in the sitting position. Second, we will discuss 
the changes observed in both the control and COPD subjects when going from the sitting to 
the supine position since these changes can potentially help us understand the pathogenesis of 
orthopnea. Interestingly, some of these changes were more pronounced in the COPD group 
and the changes in IC with position were opposite in the two groups which also has important 
consequences for the interpretation of the data. Third, within the COPD group, we will dis-
cuss differences found between orthopneic and non-orthopneic subjects firstly according their 
answer to the presence of orthopnea in everyday life and second according to the change in 
dyspnea observed with position during the experimental procedures. As will be discussed, 
these results point towards an increased small airway obstruction in the supine position which 
probably plays an important role in the genesis of orthopnea in COPD.  
6.1. Difference between COPD and control subjects in the sitting position 
Although gender and other anthropometric were well balanced between the COPD and 
control group, the latter was significantly younger and had a significantly lower waist to hip 
ratio. The higher waist to hip ratio observed in the COPD group might be related to age as this 
ratio increases with age in both genders [46]. 
6.1.1. Spirometry 
As expected and by definition, forced parameters obtained by spirometry were always 
higher in normal subjects for each of the five parameters. IC was also lower in COPD subjects 
due to their lung dynamic and static hyperinflation. VC was also significantly decreased in 
COPD subjects; this was explained by the increased RV due to the loss of elastance of the 
alveoli and small airway closure. The increase in RV is greater than the increase in TLC 
which explains the decreased IC in COPD subjects. 
6.1.2. Resistance 
The present study was concordant with the results reported in other studies such as the 
ECLIPSE study [47]. Indeed, the resistance of the respiratory system is increased in COPD 
due to the different physiopathological changes observed with the disease. In accordance with 
the literature, R5 was much higher than R20, suggesting an obstruction predominantly at the 
level of the small airways in COPD subjects. Accordingly and as seen on Figure 7, there was 
a frequency dependency of resistance in COPD but not in control subjects. This translates in a 
higher R5-20 in COPD subjects. As discussed before, this parameter is considered as a good 





Parameters derived from reactance are related to the elastance of the respiratory system. As 
discussed before, in dynamic conditions such as during tidal breathing, reactance is however 
also influenced by other factors related to airway function [50, 51] such as:  
 The choke point phenomenon occurring in airways in case of EFL; 
 The phenomenon of small airway closure.  
As can be seen from Table 5, the greatest proportion of the increase in X5 observed in 
COPD subjects was found in the expiratory phase of the breathing cycle. As the diameter of 
the small airways is reduced in expiration as compared to inspiration, this suggests that the 
increase in reactance observed in COPD subjects was mostly related to dynamic factors rather 
than to an increased elastance of the respiratory system. 
We did not report the results of Fres because it was not possible to measure in the oscilla-
tion frequencies applied during the recordings in the present study in some COPD patients. 
This problem also impacts somewhat the AX measurement as the latter is underestimated in 
patients where no Fres could be determined. This problem occurs when the Fres was upper 
than 35 Hz, the upper frequency sent by the Tremoflo
TM
. 
6.2. Effect of the supine position in controls and COPD subjects 
Before discussing other results, it is important to recognize an important difference be-
tween COPD and control subjects regarding lung volumes and breathing pattern. Indeed, as 
opposed to control subjects, patients with COPD had no increase in IC in the supine position.  
As already discussed, we did not measure the FRC (which is equal to EELV) in the present 
study as body plethysmography is not feasible with usual equipment in the supine position. 
FRC can be measured in both the sitting and the supine postures with the helium dilution 
method. However, the latter has important limitations in COPD. Indeed it under evaluates 
FRC in patients with poorly ventilated lung areas which are present in COPD [52]. As the 
supine position influences small airway function as discussed below, the undervaluation of 
FRC with the helium dilution method might increase in the supine position. This probably 
explains the paucity of data in the literature regarding changes in FRC with postures in 
COPD. Available data suggest that neither TLC nor FRC (measured by the helium dilution 
method) change appreciably when adopting the supine position in severely hyperinflated pa-
tients [53]. Accordingly, we used the IC as a surrogate for FRC. Indeed, the sum of IC and 
FRC represents TLC. Postulating a constant TLC during the measurements of the present 
study, an increased IC reflects a decreased FRC and vice versa. Data from the literature sug-
gest that a constant TLC in the short term is a reasonable assumption, including when chang-
ing position from the sitting to the supine posture [41]. 
The changes in IC observed in the two groups thus suggest that FRC was significantly de-
creased in the supine position in the control subjects, as expected [37] whereas it did not 
change in the COPD group, so as observed by Tucker and Sieker [53]. This has important 
consequences for interpretation of the data since an increased airway resistance is expected 
with a decreased FRC such as when adopting the supine posture in controls, and the reverse 
when FRC increases, such as when adopting the supine position in COPD subjects [18].  
A decrease in FRC in the supine position in normal subjects has been demonstrated in sev-




explained by a shift from the venous blood from the lower limbs and splanchnic compartment 
due to gravity [41, 54]. This shift might be impaired in COPD subjects due to higher positive 
intrathoracic pressures in the expiratory part of the breathing cycle which is prolonged in case 
of airway obstruction but other factors discussed below may explain the lack of increase in IC 
in the supine position. 
Moreover, we also observed significant differences regarding the breathing pattern accord-
ing to position, which were restricted to the COPD group. Indeed, VE, breathing frequency 
and VT were significantly reduced in the supine position. This pattern of breathing is suscep-
tible to decrease alveolar ventilation and increase PaCO2. An increased PaCO2 might increase 
the chemoreceptor afferences to the respiratory centers and induce dyspnea because of neu-
romechanical uncoupling [20]. We did not measure blood gases in the present study. Alt-
hough we cannot exclude that some patients developed or had increased hypercapnia in the 
present study, it is unlikely that it played a significant role since we excluded patients with 
hypoxemic respiratory insufficiency.  
Hypoventilation might induce an increase in resistance but this has only been demonstrated 
for the upper airway resistance [55, 56].  
6.2.1. Spirometry 
As expected, FEV1 and FVC significantly decreased in the control group when adopting 
the supine posture. There was also a small but significant reduction of the Tiffeneau index. 
However, all these parameters stayed within the normal range of the American Thoracic Soci-
ety guidelines as it was the case in other studies [37, 57]. 
FEV1 and FEV1/FVC were also significantly decreased in the supine posture in COPD sub-
jects. This is concordant with data reported for example by Melam (2014) [58]. Since FVC 
was not reduced in the supine position in the COPD subjects, this suggests increased airflow 
obstruction in the supine position, as discussed below [55]. However, the decrease in FEV1, 
even if significant, was really small in absolute terms. In fact, there was only a 50 mL mean 
difference between both postures in COPD compared to a 290 mL mean difference in normal 
subjects. A 100 mL decrease is usually used as a clinically meaningful change [59]. As dis-
cussed below, the changes in FOT parameters were far more striking in the COPD group and 
this points to the fact that the FOT technique adds significantly to spirometry for the assess-
ment of the derangements of respiratory mechanics. 
As discussed above, the second run in the sitting position was used in order to ascertain 
that changes observed from the first sitting run to the supine position were indeed due to posi-
tion rather than other uncontrolled potential confounding factors. Unexpectedly, we found 
some minor differences between the two sets of runs performed in the sitting position. These 
changes observed between the two sitting positions were observed in the COPD groups for 
the slow vital capacity maneuver including the IC and the VC that were significantly lower in 
the second than the first set. These small differences might be due to the fatigue of the patient 
at the end of repeated recordings. 
6.2.2. Resistance 
In the control group, R5, R20 and R5-20 were significantly increased in the supine position as 
compared to the sitting position. This is consistent with the results of Navajas et al.(1988) 
who showed that the supine posture was associated with a significantly increased resistance in 




be explained by the reduced cross sectional area of the oropharynx lumen while the increase 
in R5 and R5-20 reflects higher small airway resistance in the supine position which is probably 
accounted by a reduced FRC in the supine position. The latter is suggested by an increased 
IC. Another potential explanation for the increased R5-20 is the changes due to gravity in the 
supine posture. The latter is associated with a larger portion of the lung volume in the depend-
ent zone (dorsal part of the thoracic cage) where the pleural pressure is higher, meaning that a 
bigger portion of the small airways will have a reduced airway diameter. These explanations 
for the changes in airway resistance apply for both groups with the notable exception of the 
decreased FRC, as suggested by the decreased IC in the COPD group. 
In the COPD group R5, R20 and R5-20 were also increased in the supine posture and this in-
crease was similar to the control group for R5 and R20. R5-20 however increased more im-
portantly in the COPD group than in the control group despite the decrease in IC. This en-
hances the fact that the position itself influenced the small airway diameter. Part of the in-
crease in R20 in the COPD group might be explained by the change in breathing pattern ob-
served in the supine position [55, 56]. 
6.2.3. Reactance 
In normal subjects, the small but significant increase in X5 and X5in may be related to small 
airway closure. The closing capacity, which is the highest lung volume at which small airway 
closure appears, decreases with age. Moreover, the closing capacity is closer to FRC in the 
supine position. Accordingly, the closing capacity is usually close to FRC in healthy subjects 
older than 65 in the sitting position but already around 45 years onwards in the supine pos-
ture[60]. 
The changes observed for reactance parameters in COPD subjects with position were much 
more pronounced than in control subjects. The most important changes were observed for 
ΔX5 and X5ex. This suggests that dynamic changes in the expiratory part of the breathing cycle 
explain these changes, most probably due to the appearance of EFL secondary to increased 
small airway obstruction. The changes in ΔX5 and X5ex which suggest EFL might also explain 
the reduced IC due to DH observed in the supine posture in COPD subjects. The reduced IC 
also can contribute to orthopnea [20, 60]. 
According to the 2,8 cmH2O.s/L ΔX5 threshold for defining EFL, only one control subject 
presented an EFL in the supine posture [36]. This subject was a 72 years old woman. She also 
experienced an R5-20 and AX in the supine position. In the COPD group, the number of sub-
jects having a ΔX5 above 2,8 cmH2O.s/L went from 18 subjects in the sitting position to 31 
subjects in the supine posture.  
6.3. Difference between orthopneic and non orthopneic 
Subjects defining themselves as orthopneic in the daily life did not differ much from non 
orthopneic subjects regarding anthropometric parameters or lung function parameters meas-
ured in the sitting position. 
Interestingly, we found a significantly lower waist to hip ratio in orthopneic patients. We 
could imagine that because the waist to hip ratio is bigger in the non-orthopneic group nor-
mally these subjects should have a greater impairment. However, O’Donnell et al. (2012) 
have already showed the presence of a relationship between overweight (OW)/obesity (OB) 
and lung function in COPD subjects [61]. In OW/OB subjects, there was an increase in 





Orthopneic subjects already had a higher dyspnea-VAS in the sitting position, suggesting 
that the severity of dyspnea in the erect posture is a predisposing factor for experiencing or-
thopnea. 
There were no significant differences regarding GOLD stages proportion or FEV1 suggest-
ing that orthopnea prevalence was not significantly influenced by disease severity as assessed 
by FEV. However, IC was smaller in orthopneic subjects than non-orthopneic. IC reduction 
has already been associated with increased dyspnea, which underlies the role of hyperinflation 
in the genesis of dyspnea both in the erect as in the supine posture as discussed below [63].  
Quite unexpectedly however, there were no significant differences in the sitting posture be-
tween orthopneic and non-orthopneic patients in FOT parameters, although there was a ten-
dency for a greater impairment for both the resistance and reactance parameters. The results 
were however influenced by a severe outlier in the non orthopneic group. When the statistical 
analysis was controlled after exclusion of this outlier, significant differences were found for 
R5 and X5in. 
In the supine posture, orthopneic subjects also had a decreased IC associated with an in-
creased dyspnea VAS compared to non-orthopneic (with and without the outlier). Neverthe-
less, they also had higher R5 and R20, and X5. Here again the results were influenced by the 
same outlier. When excluded, we found significant differences in all FOT parameters related 
to reactance, and particularly ΔX5, suggesting an association between EFL and orthopnea. 
This is also suggested by a strong tendency for a higher proportion of orthopneic patients de-
fined as EFL according to the 2,8 cmH2O.s/L threshold for ΔX5.  
6.4. Difference between subjects having or not an increased VAS in supine 
As assessing orthopnea in the daily life in a binary fashion is subject to limitations due to 
the multiple dimensions of dyspnea sensation as well as its complex pathophysiology, we 
were interested to measure dyspnea and its changes with posture in a more quantitative way 
during the experimental procedures with the aid a VAS. More precisely, we assessed the as-
sociations between changes in VAS and  
 Various parameters (anthropometric, spirometric’s and FOT parameters) and  
 Changes in various parameters related to respiratory function from the sitting to the 
supine position. 
We could not demonstrate any significant correlations between the dyspnea VAS changes 
with posture and anthropometric, spirometric’s or FOT measurements either in the sitting or 
the supine position. However, there were significant correlations between changes in the 
dyspnea VAS from the sitting to the supine posture and changes with posture in ∆X5, X5, X5ex 
and AX. As discussed above, these parameters are influenced by the presence of EFL and 
potentially airway closure. These results again suggest that an increase in dyspnea in the su-
pine position is related to an increase in EFL in that position. This is in accordance with the 
findings of Eltayara et al. (2001) who showed that orthopnea was related to EFL in the supine 
position, as assessed by the negative expiratory pressure technique [16]. 





7. Study limitations 
This study had some limitation. Firstly, the control group was younger than the COPD 
group and it is know that resistance, reactance and spirometric’s measurements are influenced 
by age [44]. However, age cannot explain by itself the differences observed between the 
COPD group and control group. Indeed, the comparison of the results expressed in predicted 
value (according height, weight and age) when available also showed significant differences 
between the two groups.  
Another limitation of the study is the absence of direct measurement of FRC in the present 
study. It was postulated that TLC was unchanged in the supine posture and so we used IC to 
infer changes in FRC. Even if applying this to our control group showed results similar to 
those seen in the literature for normal subjects we cannot exclude that TLC significantly 
changed with posture in the COPD patients. As discussed above, would FRC be measured by 
the helium dilution method, it will be underestimated [52]. On the contrary, body plethysmog-
raphy would overestimate the FRC because the body plethysmography method assumes that 
the change in alveolar pressure is equal to the change in mouth pressure. This assumption is 
not true as the alveolar pressure is underestimated by mouth pressure measurements if a small 
flow is produced during the maneuver against the closed shutter. This results in an overesti-
mation of the FRC with while body plethysmography. The higher the airway resistance the 
higher will be the overestimation so that the changes in posture might also result in different 
overestimations of FRC by the body plethysmography method [64]. 
8. Conclusion and perspectives 
This study highlighted the high prevalence of orthopnea in COPD since more than 50% of 
the patients included in the present study reported or experienced orthopnea during the exper-
imental procedures. 
We also confirmed that FOT parameters are significantly different between normal and 
COPD subjects. This is true for both resistance and reactance parameters.  
To the best of our knowledge, this study is the first to report the changes in FOT parame-
ters induced when adopting the supine posture in COPD subjects. As expected, we observed 
significant increases in resistance parameters in controls which are largely influenced by the 
decrease in EELV reflected by an increased IC. 
On the contrary, the IC decreased in the supine posture in COPD, suggesting an increase in 
FRC. This points to the fact that other factors are at play to explain the increase in resistance 
parameters observed in the supine position in COPD subjects. As there were also marked in-
crease in the reactance parameters in the supine posture and as those were particularly promi-
nent in the expiratory part of the breathing cycle, this suggests that the small airway obstruc-
tion increases when COPD are going supine, leading to EFL and DH. 
We also were able to show significant differences between orthopneic and non-orthopneic 
COPD subjects. These comparisons also point to the role of small airway changes induced by 
posture to explain orthopnea.  
This study was able to show the relevance of FOT to assess orthopnea. An increase in the 
dyspnea-VAS in the supine posture was only correlated with changes in FOT parameters: an 
increase of AX and ΔX5 and a decrease of X5 and X5ex from the sitting to the supine posture. 




results suggest that EFL is an important mechanism implicated in the genesis of orthopnea in 
COPD subjects, confirming results obtained by the NEP technique by Eltayara et al. (2001). 
EFL on its turn can explain the reduced IC observed in the supine position in COPD subjects. 
A reduced IC is known to induce dyspnea by increasing the workload imposed to inspiratory 
muscles. 
In order to confirm on one hand the results of the study and on the other hand the role of 
EFL and the increased closing capacity in FOT parameters changes and orthopnea, we can 
image the addition of two different tests: 
 the negative expiratory pressure technique to confirm the association between reac-
tance parameters and EFL;  
 the nitrogen washout technique to test the hypothesis that reactance parameters are 
influenced by the closure of small airways since this method had already been used 
to assess the closing capacity in anesthetized subjects [65, 66]. 
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Evaluation de l’effet de la position sur la mécanique respiratoire par 
la technique des oscillations forcées chez des sujets normaux et 
souffrant de BPCO. 
Nom, prénom du patient : 
_______________________________ 








1.  Données personnelles : 
 
 Date de naissance :          /            /            
 Age : _______________ 
 Sexe :           Homme   -    Femme  
 Tabagisme :    Oui     -    Jamais    -    Ancien(ne) fumeur-se 
 
Nombre de cigarettes par jour : ____________________  
 
Nombre de paquet par année : _____________________ 
 
 
2. Données anthropomorphiques : 
 
 Poids : ____________________ 
 Taille : ____________________ 
 Tour de taille : ______________ 
 Tour de hanche : ____________ 
 IMC : _____________________ 
 
 
3. Données médicales : 
 
a) Pour patients sains :  
Souffrez-vous d’une maladie respiratoire chronique ? 
La ou lesquelles ; depuis quand 
 
 
Souffrez-vous d’une maladie cardiaque? 
La ou lesquelles ; depuis quand 
 
 
b) Pour patients BPCO : 
Depuis quand êtes vous soigné pour votre bronchopneumopathie 
chronique obstructive (bronchite chronique-emphysème) ; depuis 








- Avez-vous présenté une dégradation de votre état respiratoire  
ayant nécessité la prise d’antibiotiques ou de corticostéroïdes 
(Medrol) au cours des 12 derniers mois ? Quand (date), combien 











                                     







         _____________________________________________________ 
         _____________________________________________________ 
         _____________________________________________________ 
































6. Traitement : 
 
a) Quels médicaments prenez-vous actuellement ? 





















b)   A quelle heure avez-vous pris vos inhalés médicaments la dernière fois ? 
 
1 Médicament :    Date et heure 
2 Médicament :    Date et heure 





7. Examen : 
 










Vous sentez-vous plus essoufflé en position couchée, tout-
à-fait à plat ? 
 
    1            2         3          4           5         6 
                                            
   Tout-à-fait                                                                                         Pas du tout  



























Pouvez-vous mettre un trait vertical sur la ligne ci-dessous (sachant qu’une 
extrémité est représentée par l’absence d’essoufflement au repos et que l’autre est 
représentée par un essoufflement maximal) afin que nous puissions voir comment 
vous évaluez votre dyspnée ? 
 

























Position couchée : 
 
 









































Pas d’essoufflement                                                             Essoufflement 
maximal 
 
____________________ 
 
